🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI
$70.71
+71.85% 1Y
P/E103.99
52W High$72.42
52W Low$34.70
EPS (TTM)$0.68

Company Overview

CGNX (CGNX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Healthy Margins

Operating margin of 16.4% supports profitability.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $994.36M (+8.7% YoY); net profit $114.44M.
  • Trailing 12 Months Year-on-year growth — revenue +8.7%, earnings +7.8%.
  • 5-Year Trend Long-term compounding — revenue CAGR 8.6%, profit CAGR 8.8%.

Growth & Price Performance

Compounded Sales Growth

5 Years:8.65%
1 Year:8.73%

Compounded Profit Growth

5 Years:8.80%
1 Year:7.79%

Stock Price Performance

1 Year:+71.85%
6 Months:+73.59%
3 Months:+20.36%
1 Month:+10.12%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 95% of range
$34.70 $72.42
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)62.30 · Neutral
Price Performance
1M+10.12%
3M+20.36%
6M+73.59%
1Y+71.85%

Auto-generated from price history and fundamentals; not investment advice.

Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 104.0.

* The pros and cons are auto-generated from financial metrics.

Ad space

Valuation

Stock P/E
103.99
Industry PE
-
Forward P/E est.
96.47
PEG Ratio
-
Book Value
$-
Price to Book
-
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
8.65%
Profit 5Y
8.80%
Revenue (YoY)
8.73%
Earnings (YoY)
7.79%

Profitability & Returns

ROCE
8.87%
ROE
7.67%
ROA
5.68%
Profit Margin
11.51%
Op Margin
16.35%
Gross Margin
66.92%
EPS (Latest Qtr)
$0.31
EPS (TTM)
$0.68

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
-
Total Assets
$2.01B
Current Assets
-
Working Capital
-

Ownership

Promoter Holding
0.37%
Chg in Prom Hold
-
FII / Inst Holding
104.67%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$994.36M
EBITDA
-
Free Cash Flow
$236.77M
Operating Cash Flow
$245.51M
Shares Outstanding
-
Gross Margin
66.92%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2014Sep 2014Apr 2015Jul 2015Oct 2015Apr 2016Jul 2016Oct 2016Apr 2017Jul 2017Oct 2017Dec 2017Apr 2018Jul 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Apr 2021Jul 2021Oct 2021Apr 2022Jul 2022Oct 2022Apr 2023Jul 2023Oct 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Apr 2026
Revenue --------169.57M211.26M232.22M193.29M173.48M199.05M183.32M169.77M173.48M199.05M183.32M169.77M167.24M169.10M251.07M223.62M239.03M269.16M284.85M282.41M274.63M209.62M201.12M242.51M197.24M210.80M239.29M234.74M216.04M249.09M276.89M268.44M
Gross Profit 74.09M116.64M79.03M113.32M81.27M75.24M112.06M115.20M129.37M157.09M173.36M140.46M127.20M148.08M135.69M124.90M127.20M148.08M135.69M124.90M126.03M118.78M191.33M168.46M184.98M200.73M199.14M203.62M196.49M152.24M143.74M179.68M142.77M141.94M166.60M159.40M144.32M167.88M187.29M190.94M
Operating Income 26.02M55.34M22.11M51.78M28.48M16.34M49.67M54.53M34.60M63.45M77.84M45.25M30.15M51.76M43.09M17.61M30.15M51.76M43.09M17.61M20.95M-6.14M96.64M59.09M78.45M92.58M87.55M86.73M65.14M40.02M22.16M65.17M30.64M14.20M38.46M31.56M26.09M43.43M57.77M59.87M
Net Income 25.95M50.40M20.50M43.71M104.11M14.88M42.76M53.67M37.22M56.20M80.44M45.42M33.10M48.75M41.69M80.33M33.10M48.75M41.69M80.33M20.48M-1.14M87.51M69.34M69.85M77.60M78.90M67.33M58.90M33.98M25.61M57.47M18.92M12.02M36.21M29.59M23.60M40.51M17.66M51.70M
Diluted EPS 0.290.570.230.491.190.170.490.610.210.320.450.260.190.280.240.460.190.280.240.460.12-0.010.490.390.390.430.440.380.340.190.150.330.110.070.210.170.140.240.100.31
R&D Expense 12.52M17.53M16.99M18.30M16.98M20.55M19.67M18.60M22.77M23.38M26.08M-31.08M26.89M29.70M-30.24M28.08M28.11M-35.95M30.40M30.24M-34.10M31.30M34.48M36.05M33.99M33.95M38.54M33.59M32.58M37.10M34.96M35.21M34.73M33.10M35.08M37.02M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 242.68M175.73M290.69M321.91M324.28M307.65M426.45M450.56M529.51M766.08M806.34M725.62M811.02M1.04B1.01B837.55M914.51M994.36M
Gross Profit 174.25M119.34M213.10M244.00M244.78M244.76M332.38M347.99M398.44M578.79M600.29M535.87M604.60M759.83M721.90M601.24M625.79M665.39M
Operating Income 25.10M-12.67M75.71M85.36M83.41M76.94M127.85M121.52M154.07M258.86M221.14M142.60M170.53M315.10M246.23M130.70M115.06M162.57M
Net Income 27.27M-4.87M61.38M69.87M68.10M73.57M121.48M187.07M143.69M176.71M219.27M203.87M176.19M279.88M215.53M113.23M106.17M114.44M
Diluted EPS 0.66-0.121.520.820.780.831.361.060.830.981.241.161.001.561.230.650.620.68
R&D Expense 36.26M31.13M33.08M40.95M41.55M44.31M55.83M69.79M78.27M99.20M116.44M119.43M130.98M135.37M141.13M139.40M139.81M138.97M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --439.87M533.10M611.88M627.61M709.70M821.73M887.76M1.04B1.29B1.29B1.89B1.80B2.00B1.96B2.02B1.99B2.02B
Total Equity 476.37M413.07M394.45M473.31M552.98M572.28M643.91M736.44M832.33M963.38M1.10B1.14B1.36B1.26B1.43B1.44B1.50B1.52B1.49B
Cash & Equivalents 104.14M127.14M119.83M33.20M38.10M45.16M40.64M55.69M51.98M79.64M106.58M108.21M171.43M269.07M186.16M181.37M202.66M186.09M262.93M
Total Liabilities -------85.30M62.09M76.00M192.08M154.40M530.23M538.50M573.57M519.75M513.06M475.35M524.65M
Current Liabilities --38.68M54.43M54.10M50.10M61.02M80.67M53.69M65.77M112.64M91.36M120.48M132.30M188.59M187.71M151.88M169.38M183.55M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 58.94M12.28M76.33M86.28M101.13M95.45M163.84M128.33M182.08M224.32M223.45M253.31M242.40M314.06M243.41M112.92M149.08M245.51M
Investing Cash Flow 64.54M-466.00K-176.48M-90.21M-38.85M-88.07M-104.10M-10.55M-121.83M-105.56M-10.83M-157.34M169.44M-252.54M-4.45M32.27M-38.97M28.02M
Financing Cash Flow -95.53M-21.30M20.23M9.79M-45.15M-12.46M-42.74M-116.83M-29.23M-100.12M-209.90M-32.23M-316.87M-141.62M-240.37M-125.61M-118.42M-206.69M
Capital Expenditure -6.01M-5.47M-5.85M-7.82M-9.88M-9.63M-20.93M-18.23M-12.82M-28.75M-37.09M-21.75M-13.30M-15.46M-19.67M-23.08M-15.04M-8.74M
Free Cash Flow 52.92M6.82M70.48M78.45M91.25M85.83M142.91M110.10M169.26M195.57M186.36M231.57M229.10M298.61M223.74M89.84M134.04M236.77M
Share Buybacks 92.97M--10.00M047.91M59.67M126.35M47.15M123.72M203.82M61.69M51.04M161.65M204.31M79.79M67.08M151.23M
Dividends Paid -------18.06M25.21M29.04M31.86M35.12M390.51M43.26M45.92M---

Ratios (Annual)

Figures in %.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 71.8%67.9%73.3%75.8%75.5%79.6%77.9%77.2%75.2%75.6%74.4%73.8%74.5%73.3%71.8%71.8%68.4%66.9%
Operating Margin % 10.3%-7.2%26.0%26.5%25.7%25.0%30.0%27.0%29.1%33.8%27.4%19.7%21.0%30.4%24.5%15.6%12.6%16.3%
Net Margin % 11.2%-2.8%21.1%21.7%21.0%23.9%28.5%41.5%27.1%23.1%27.2%28.1%21.7%27.0%21.4%13.5%11.6%11.5%
ROE % 6.6%-1.2%13.0%12.6%11.9%11.4%16.5%22.5%14.9%16.1%19.3%15.0%14.0%19.6%15.0%7.5%7.0%7.7%
ROCE % --3.2%15.8%15.3%14.4%11.9%17.3%14.6%15.8%22.0%18.5%8.1%10.2%17.4%13.9%7.0%6.3%8.9%

Shareholding Pattern

Insiders
0.37%
Institutions
104.67%
Public Float
105.06%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for CGNX

Google News Wed, 05 Aug 2026

Hundreds of customers use Cognex’s OneVision platform for AI-powered vision applications - Stock Titan

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPRlBOdmp2WTZJS1V5RDBTTDdvVmZ4eWp4eHFqd1VwWFdIRThZOVFGelBwa0gzdi1sbUltcjFobGVsN3Q5UEJadXRZVzVPaGZXbzY2OW5keWdiUVVXOTl3ZjBmcmRiS1laRS1qbG5Obmg4OElmVTQ3cTRLc3NKbWV0Zkl2Rm5qWHg2dFBySl…

Google News Fri, 17 Jul 2026

Cognex (CGNX) Stock Looks Overvalued On Cash Flow And Earnings - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQaEJhY3FnanhITUpRcHNSY3pmb1Y3RFpvWG5IN0hYcnhUX183ZllKeVFRRW1JODZGODNKUFpXeHR0eE93VGl3Y29vQ25xM3phMXMxYTNMOXJBYkNvcHN1THJ3TlZ1bzRzUk9jNk5RNTlPYmJTa3NfdUtiREdkWHV6REVRLWlnM3JsT3ZMd2…

Google News ue, 04 Aug 2026

Cognex Corp (CGNX) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 81/100 - GuruFocus

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOTjA4UnQwX3g3QXNSWXQ0cWFKMU9obHFHOGw3bi1sZE13NnFlb05QOHRGWXpQZXlrRXNTVlozMmhsaGx1Qlo1b1lKenViNXF0bkgxSzR5WlZEelRxSDhTTTd2LW1fa1dFNy04ZDJkNEgtS1dZN0x3MVE3RXlZQ205YUE0NEo0WFZpQUJobE…

Google News hu, 30 Jul 2026

Cognex (CGNX) Stock Looks Strong On Earnings But Overvalued On Cash Flow - webull.com

<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTFBESFNQeElFU3ByaTJSLXdvUVZXajMwMW1MTWdBa2hDUnotU1dleGRNZDJNbWJrOXRnNEc1a2pkVG84SmxlYlprUzRfb29YM0taVy1YYTZFSm4?oc=5" target="_blank">Cognex (CGNX) Stock Looks Strong On Earnings But…

Google News ue, 04 Aug 2026

Cognex (CGNX) Q2 Earnings Report Preview: What To Look For - StockStory

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOd3hXa0ZhWmFCeWZ1anFOT0NKRUoyYjk5VjBmRTBsaG42Z25KZ2xRd2I1a3diWXRMWkJQOFFrU2NSM2gxUXMyc3dWR1FhRWluQUFPR0RXVkdGVUh5aHRMUi1iQmtqYVZkQjUzWXpoN3lDaDhwNXFJUUJwOWdpdllzY0FDaE5NRnZNNUhvWk…

Google News Wed, 05 Aug 2026

Cognex (NASDAQ:CGNX) Misses Q2 CY2026 Revenue Estimates - FinancialContent

<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxQM05ZZkFlSC16dGlvc1N1M1A3TG82bHpHVTFzdEliUFBpY3ZDWVBPeTZ1cExXdkxSR2xTYWxWekhxbXcyYVJlSXdsT3h2SXBuQ2hxVEpxTzVYZ2RjR3l5RDFPQjFpUVpYQXJEX1dNSnRzWDdfS0FHLTJHdlZaR09pT0s0QWFENnNCLUlibH…

CGNX — Frequently Asked Questions

What is the current share price of CGNX?

As of 2026-08-05 17:25 PDT, CGNX trades at $70.71 on NASDAQ/NYSE. Its 52-week range is $34.70 to $72.42.

What is the P/E ratio of CGNX?

CGNX trades at a trailing price-to-earnings (P/E) ratio of 103.99.

What is the return on equity (ROE) of CGNX?

CGNX has a return on equity (ROE) of 7.67%. Its return on capital employed (ROCE) is 8.87%.

Is CGNX a good stock to buy?

This page provides a data-driven analysis of CGNX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks